1. SPARROW SPRI: The SPRI system launched by AFFINITY SENSING TECHNOLOGY CO., LTD. features industry-leading ultra-high sensitivity and a wide dynamic range, providing stable and reliable detection data across a variety of application environments. Combined with the innovative design of disposable microfluidic chips, it not only effectively reduces the risk of cross-contamination but also makes the operational workflow faster and simpler. Its compact system architecture gives it significant advantages in portability and point-of-care testing (POCT), allowing users to quickly obtain high-quality biomolecular interaction information in clinical settings, laboratories, or outdoor environments. Whether for medical diagnostics, drug development, or rapid on-site analysis, the SPRI platform from AFFINITY SENSING TECHNOLOGY CO., LTD. delivers an efficient, professional, and trustworthy measurement experience.
2. Dual Syringe Pump System: The dual syringe pump system developed by AFFINITY SENSING TECHNOLOGY CO., LTD. features highly stable flow control, which effectively reduces noise interference caused by fluid pressure fluctuations. With its outstanding fluid stability, this system can be more efficiently paired with the SPARROW Surface Plasmon Resonance (SPR) instrument, further enhancing the accuracy, stability, and reproducibility of the detection process.
(The content above was translated by AI.)

The "Disposable-Gate Nanoelectronic Biomedical Detection Platform" technology is a world-leading, innovative detection method. Its sensitivity has reached the sub-fM (< 10^-15 M) level, which is over a thousand times higher than currently used detection methods, while reducing the detection time from several hours to just 20 minutes. The technical team has successfully completed validation for various target analytes, including Botulinum toxin, Hepatitis B antigen proteins, and Streptococcus pneumoniae. Featuring 8 channels with continuous scalability, this detection platform can simultaneously detect different biomarkers, providing an outstanding diagnostic tool for early-stage cancer and other diseases.
(The content above was translated by AI.)

The core product is a nano‑electrode array chip with inter‑electrode spacing of approximately 70 nm and tip diameters of ~40 nm, enabling strong electric fields at the single‑cell scale for non‑contact cell positioning, transfection or lysis. The technolo

The primary research and development projects are divided into molecular detection instruments and reagents. The proprietary reagents developed, when paired with the instruments, offer an absolute advantage in both nucleic acid extraction concentration and purity compared to products from competing manufacturers.
(The content above was translated by AI.)